Anvisa Records Two New Semiglutide Slimming Pens - Tribuna Do Norte
10 Articles
10 Articles
Anvisa approves two new semaglutide injection medicines in Brazil, including a generic and a similar one for type 2 diabetes.
The National Agency of Sanitary Surveillance (Anvisa) approved on Tuesday (10) two new agonist injectable drugs of the GLP-1 receptor, popularly known as weight loss pens. These are: generic of semaglutide and Loryvia (similar product). In a note, Anvisa highlighted that both devices have as active principle to semaglutide and are indicated for the treatment of [...] The post Anvisa records two new weight loss pens of semaglutide first appeared …
Now, Brazil already has 22 records of injectable medicines for the treatment of diabetes in 2026
The National Agency for Health Surveillance (Anvisa) approved the registration of two new injection pens based on semaglutin, the so-called weight loss pens, being a generic and similar version, marketed under the name Loryvia. The authorisations were published on Tuesday (10/11).According to the agency, the medicines are indicated for adults with type 2 diabetes mellitus who cannot adequately control the disease. To verify the efficacy and safe…
The National Agency of Health Surveillance (Anvisa) approved on Tuesday (10) two new agonist injectable drugs of the GLP-1 receptor, popularly known as weight-loss pens. They are: generic of semaglutide and Loryvia (like product).In a note, Anvisa highlighted that both devices have as active principle to semaglutide and are indicated for the treatment of diabetes. The two products have as matrix the product Ofozy and the records were granted to …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium










